Author

Toshio Kitamura

Institutions: Foundation for Biomedical Research and Innovation, The University of Tokyo

Observed institutions: Foundation for Biomedical Research and Innovation, The University of Tokyo

ORCID: 0000-0001-7855-1767

Observed ORCID: 0000-0001-7855-1767

OpenAlex ID: A5066832280

ASXL1 mutation-related clonal hematopoiesis and age-related diseases: clinical evidence and molecular insights

2025 · Naru Sato, Susumu Goyama, et al. · International Journal of Hematology · 19

SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiation

2024 · Yu-Hsuan Chang, Keita Yamamoto, et al. · Cell Reports · 16

Recruitment of BRD4 to the ASXL1 genomic targets depends on the extra-terminal domain of BRD4

2026 · Karthik Selvam, Shuang Lu, et al. · Nature Communications · 2

Highly Senescent Subpopulation of Failed Repair Proximal Tubular Cells Drives Kidney Injury Progression

2026 · Ryo Yamada, Koji Muro, et al. · Journal of the American Society of Nephrology

MECOM promotes leukemia progression and inhibits mast cell differentiation through functional competition with GATA2

2026 · Kohei Iida, Mayuko Nakanishi, et al. · Leukemia

Wcn26-3421 the Discovery and Analysis of a Unique Subpopulation of Proximal Tubular Cells Exhibiting Phenotypes Indicative of Senescence

2026 · Ryo Yamada, Koji Muro, et al. · Kidney International Reports

Latent mitotic vulnerability of AML cells induced by therapeutic agents

2024 · Ryuta Niikura, Tomohiro Yabushita, et al. · bioRxiv (Cold Spring Harbor Laboratory)

hkawaji/dpi1: Decomposition-based peak identification, which find peaks across a large number of TSS (transcription starting site) profiles

2013 · Shuhei Noguchi, Takahiro Arakawa, et al. · King Abdullah University of Science and Technology Repository (King Abdullah University of Science and Technology)

Works count: 8

Citation count: 37

H-index: 2

I10-index: 2